Research Alliance Corporation III functions as a blank check company, also referred to as a Special Purpose Acquisition Company (SPAC). Its primary ...
Research Alliance Corporation III (RACC) is a newly formed special purpose acquisition company (SPAC) incorporated in the Cayman Islands, with headquarters in New York City. Founded on February 19, 2026, the company was established with the sole purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or ...Research Alliance Corporation III (RACC) is a newly formed special purpose acquisition company (SPAC) incorporated in the Cayman Islands, with headquarters in New York City. Founded on February 19, 2026, the company was established with the sole purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. The company is sponsored by an affiliate of RA Capital Management, L.P., a healthcare-focused investment firm, which suggests a potential focus on the life sciences and healthcare sectors, although no specific target has been identified yet.
In May 2026, RACC priced and completed its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share, raising gross proceeds of $75 million. The shares began trading on the NASDAQ Global Market under the ticker symbol 'RACC' on May 20, 2026, following SEC effectiveness on May 19, 2026. The proceeds from the IPO are held in trust and will be used to finance the business combination, with the company having a typical SPAC timeline to complete a deal (usually 18-24 months).
Leadership is headed by CEO Matthew D. Hammond, Ph.D., MBA, who brings extensive experience in life sciences investing and company building. He is supported by CBO/COO Henry Stusnick, who has a background in operations and business development. The team aims to leverage their sector expertise to identify and acquire a promising company, potentially in the healthcare, biotech, or pharmaceutical industries.
As a SPAC, RACC has no operational revenue or products, and its financial performance is minimal outside of the trust funds and IPO proceeds. The company's success depends entirely on completing a successful business combination and creating value for shareholders. As of now, RACC has no employees (or a very small team), and its employee count is minimal, typical for a SPAC at this stage.
Given the early stage, the company's stock price has been volatile, trading in a range of $10.21 to $27.41, with a recent price of $26.66, reflecting market speculation and expectations of a potential acquisition. The market capitalization is approximately $277.9 million, indicating investor confidence in the management team and the potential for a favorable deal.
In summary, RACC is a blank check company that provides an investment vehicle for investors to participate in a future business combination, with a seasoned leadership team and strong sponsorship from RA Capital Management. Its future prospects hinge on the successful identification and acquisition of a high-growth target company.
Founded
2026
Employees
0-100
CEO
Matthew D. Hammond
Full Name
Research Alliance Corporation III Class A Ordinary Shares
